Post Intravitreal Injection Topical NSAID vs. Patching

Status unconfirmed · Phase 4 · Has a placebo group

Conditions studied: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion

In brief

A prospective randomized trial, to evaluate post-injection comfort measures comparing topical NSAID (nepafenac 0.3% suspension) and patching.

Key facts

Study ID

NCT03918590

Run by

The New York Eye & Ear Infirmary

People needed

60

Starts

2018-12-03

Expected to finish

2019-06-03

Last updated by the study team

2019-04-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Already scheduled for anti-VEGF injection based on standard of care for disease process.
• Ability to provide written informed consent
• Capable of complying with study protocol.
• Volunteer written informed consent with the understanding that consent may be withdrawn by the subject at any time without prejudice to future care

You may not qualify if…

• History of past intraocular injection of steroid medication.
• Experiencing baseline eye pain
• Monocular; non-study eye with VA<20/100.
• Unwilling or unable to follow or comply with all study related procedures

Where it is running

• New York Eye and Ear Infirmary — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.